Evidence map›Paper›PMID 35341058›Full record

ArticlePeerJ2022

The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.

Anggia Prasetyoputri, Anik B Dharmayanthi, Syam B Iryanto, Ade Andriani, Isa Nuryana, Andri Wardiana, Asep M Ridwanuloh, Sri Swasthikawati, Hariyatun Hariyatun, Herjuno A Nugroho and 19 more

Abstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Anggia Prasetyoputri *Research Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Anik B DharmayanthiResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Syam B IryantoResearch Center for Informatics, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Ade AndrianiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Isa NuryanaResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Andri WardianaResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Asep M RidwanulohResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Sri SwasthikawatiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Hariyatun HariyatunResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Herjuno A NugrohoResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Idris IdrisResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Indriawati IndriawatiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Zahra NovianaResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Listiana OktaviaResearch Center for Chemistry, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Yuliawati YuliawatiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Masrukhin MasrukhinResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Erwin F HasriandaResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Linda SukmariniResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Fahrurrozi FahrurroziResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Nova Dilla YanthiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Alfi T FathurahmanResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Ari S WulandariResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Ruby SetiawanResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Syaiful RizalResearch Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Ahmad FathoniResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Wien KusharyotoResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Puspita LisdiyantiResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Ratih A NingrumResearch Center for Biotechnology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.
Sugiyono Saputra *Research Center for Biology, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Indonesia is one of the Southeast Asian countries with high case numbers of COVID-19 with up to 4.2 million confirmed cases by 29 October 2021. Understanding the genome of SARS-CoV-2 is crucial for delivering public health intervention as certain variants may have different attributes that can potentially affect their transmissibility, as well as the performance of diagnostics, vaccines, and therapeutics. Objectives: We aimed to investigate the dynamics of circulating SARS-CoV-2 variants over a 15-month period in Bogor and its surrounding areas in correlation with the first and second wave of COVID-19 in Indonesia. Methods: Nasopharyngeal and oropharyngeal swab samples collected from suspected patients from Bogor, Jakarta and Tangerang were confirmed for SARS-CoV-2 infection with RT-PCR. RNA samples of those confirmed patients were subjected to whole genome sequencing using the ARTIC Network protocol and sequencer platform from Oxford Nanopore Technologies (ONT). Results: We successfully identified 16 lineages and six clades out of 202 samples (male Conclusions: We demonstrated a shift in SARS-CoV-2 variants from the first wave of COVID-19 to Delta variants in the second wave, during which the number of confirmed cases surpassed those in the first wave of COVID-19 pandemic. Higher proportion of unique mutations detected in Delta variants compared to the first wave variants indicated potential mutational effects on viral transmissibility that correlated with a higher incidence of confirmed cases. Genomic surveillance of circulating variants, especially those with higher transmissibility, should be continuously conducted to rapidly inform decision making and support outbreak preparedness, prevention, and public health response.

Indexed as

COVID-19SARS-CoV-2FemaleHumansIndonesiaMalePandemicsBogorCOVID-19Delta variantsGenomic surveillanceIndonesian lineagesNanoporeSARS-CoV-2Variant shifting

Identifiers

PMID35341058
PMCPMC8953504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.